Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORNOXICAM vs LOVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORNOXICAM vs LOVASTATIN: Safety Overview

Metric LORNOXICAM LOVASTATIN
Total FAERS Reports 118 1,387
Deaths Reported 6 204
Death Rate 5.1% 14.7%
Hospitalizations 61 287
Average Patient Age 58.6 yrs 60.2 yrs
% Female Patients 49.5% 55.9%
FDA Approval Date N/A Apr 14, 2006
Manufacturer N/A Preferred Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued